Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Ghent | OTHER |
| GlaxoSmithKline | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study would like to test the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in Chronic Obstructive Pulmonary Disease (COPD) patients over a 3 month-period.
Effective pharmacologic management of Chronic Obstructive Pulmonary Disease (COPD) not only involves prescription of recommended medicines by the physician, but also implies correct use of the prescribed medication by the patient (ie, good drug adherence and correct inhalation technique). Community pharmacists could help to improve the latter aspect, by delivering pharmaceutical care. The present randomised controlled trial will study the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in COPD patients over a 3 month-period.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| control group | No Intervention | Usual pharmacist care in patients with Chronic Obstructive Pulmonary Disease (COPD). | |
| pharmaceutical care intervention | Experimental | A pharmaceutical care intervention, focused at improving inhalation technique and drug adherence in patients with Chronic Obstructive Pulmonary Disease (COPD). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| pharmaceutical care intervention | Behavioral | Pharmaceutical care intervention, focused at improving inhalation technique and drug adherence in patients with Chronic Obstructive Pulmonary Disease (COPD). |
| Measure | Description | Time Frame |
|---|---|---|
| inhalation technique baseline | Inhalation technique with Chronic Obstructive Pulmonary Disease (COPD) controller medication at baseline. | baseline |
| inhalation technique 1 month | Inhalation technique with Chronic Obstructive Pulmonary Disease (COPD) controller medication after 1 month. | after 1 month |
| inhalation technique 3 months | Inhalation technique with Chronic Obstructive Pulmonary Disease (COPD) controller medication after 3 months. | after 3 months |
| drug adherence | Adherence to Chronic Obstructive Pulmonary Disease (COPD) controller medication after 3 months. | after 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| health status | Health status, measured by: the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test, Medical Research Council (MRC) Dyspnoea Scale and Euro Quality of Life (EQ-5D) questionnaire. | baseline |
| health status |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Guy Brusselle, M.D., Ph.D. | University Hospital, Ghent | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ghent University | Ghent | Belgium | ||||
| Centre Hospitalier Universitaire du Sart Tilman |
Not provided
| Label | URL |
|---|---|
| Related Info | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Health status, measured by:
the COPD Assessment Test, MRC Dyspnoea Scale.
| after 1 month |
| health status | Health status, measured by: the COPD Assessment Test, MRC Dyspnoea Scale and EQ-5D questionnaire. | after 3 months |
| exacerbations | Frequency of exacerbations measured over a 3 month period. | after 3 months |
| Emergency Room visits and hospitalizations. | Frequency of Emergency Room (ER) visits and hospitalizations measured over a 3 month period. | after 3 months |
| Liège |
| Belgium |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |